BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30592275)

  • 1. Pain polymorphisms and opioids: An evidence based review.
    Vieira CMP; Fragoso RM; Pereira D; Medeiros R
    Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
    Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
    Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
    Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
    Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Genetic Variability Contributes to Postoperative Morphine Consumption.
    De Gregori M; Diatchenko L; Ingelmo PM; Napolioni V; Klepstad P; Belfer I; Molinaro V; Garbin G; Ranzani GN; Alberio G; Normanno M; Lovisari F; Somaini M; Govoni S; Mura E; Bugada D; Niebel T; Zorzetto M; De Gregori S; Molinaro M; Fanelli G; Allegri M
    J Pain; 2016 May; 17(5):628-36. PubMed ID: 26902643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
    Smith DM; Figg WD
    Oncologist; 2023 Mar; 28(3):189-192. PubMed ID: 36718020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
    Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
    Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
    Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
    Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
    Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
    Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.
    Lucenteforte E; Vannacci A; Crescioli G; Lombardi N; Vagnoli L; Giunti L; Cetica V; Coniglio ML; Pugi A; Bonaiuti R; Aricò M; Giglio S; Messeri A; Barale R; Giovannelli L; Mugelli A; Maggini V
    BMC Cancer; 2019 Jan; 19(1):113. PubMed ID: 30704436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
    Ho KWD; Wallace MR; Staud R; Fillingim RB
    Pharmacogenomics J; 2020 Jun; 20(3):471-481. PubMed ID: 31806881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of COMT rs4680 and OPRM1 rs1799971 Polymorphisms on Chronic Postsurgical Pain, Acute Pain, and Analgesic Consumption After Elective Cesarean Delivery.
    Wang L; Wei C; Xiao F; Chang X; Zhang Y
    Clin J Pain; 2019 Jan; 35(1):31-36. PubMed ID: 30234521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma.
    Khalil H; Sereika SM; Dai F; Alexander S; Conley Y; Gruen G; Meng L; Siska P; Tarkin I; Henker R
    Biol Res Nurs; 2017 Mar; 19(2):170-179. PubMed ID: 27903758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
    Yu Z; Wen L; Shen X; Zhang H
    Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
    Hooten WM; Hu D; Cunningham JM; Black JL
    Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation.
    Henker RA; Lewis A; Dai F; Lariviere WR; Meng L; Gruen GS; Sereika SM; Pape H; Tarkin IS; Gowda I; Conley YP
    Biol Res Nurs; 2013 Jul; 15(3):309-17. PubMed ID: 22718527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.
    Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J
    Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia.
    Aslaksen PM; Forsberg JT; Gjerstad J
    Pain; 2018 Dec; 159(12):2585-2592. PubMed ID: 30130297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
    BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.